India to Japan: Vati Export Trade Route

The India to Japan Vati corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $642 USD. The route is dominated by SREEDHAREEYAM AYURVEDIC MEDICINES PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's vati manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $642 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 79% of all shipments, consistent with vati's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 16.4%, placing it at rank #9 among India's top vati export destinations globally.

On the import side, key buyers of Indian vati in Japan include MAHARISHI AYURVEDA CO LIMITED. MAHARISHI AYURVEDA CO LIMITED is the single largest importer with 1 shipments valued at $642 USD.

India's vati exports to Japan are driven primarily by a handful of large-scale manufacturers. SREEDHAREEYAM AYURVEDIC MEDICINES PRIVATE LIMITED with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Japan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SREEDHAREEYAM AYURVEDIC MEDICINES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $642 USD reflects a mix of bulk commercial orders and smaller specialty shipments.

On the buying side, MAHARISHI AYURVEDA CO LIMITED is the largest importer with 1 shipments worth $642 USD — representing 100% of all vati imports from India on this route.